Rec. 1.b: The DoD OIG recommended that the Director of the Defense Health Agency implement procedures to review whether DoD medical treatment facility and Managed Care Support Contractor personnel are following and meeting Federal and DoD opioid safety recommendations and requirements. Specifically, the Defense Health Agency should ensure providers: 1. Complete informed consent covering the risks and benefits of opioid therapy and ensure DoD medical treatment facilities are distributing Defense Health Agency standardized informed consent forms to beneficiaries receiving opioid prescriptions. 2. Perform Prescription Drug Monitoring Program checks at least every 3 months. 3. Provide or refer beneficiaries for care in the tertiary level of the Military Health System Stepped Care Model. 4. Follow up with beneficiaries to evaluate the benefits and potential harms of continued opioid use at least every 3 months and within 1 to 4 weeks of dose escalation. 5. Monitor beneficiaries' opioid use through urine drug testing at least annually. 6. Pursue tapering opioid use to a reduced dose or to discontinuation, where appropriate.